The Guinea Pig Model: An Alternative Method for Vaccine Potency Testing: Pocket Guides to Biomedical Sciences
Autor Viviana Parreñoen Limba Engleză Paperback – 10 apr 2023
Key Features
- Reviews combined vaccines used for cattle
- Summarizes animal models used for vaccine testing
- Focuses on bovine herpesviruses, rotaviruses, parainfluenza, and bovine viral diarrhea virus
- Provides guidance on the effectiveness of the Guinea Pig model for testing vaccine immunogenicity
| Toate formatele și edițiile | Preț | Express |
|---|---|---|
| Paperback (1) | 308.75 lei 3-5 săpt. | +16.38 lei 6-12 zile |
| CRC Press – 10 apr 2023 | 308.75 lei 3-5 săpt. | +16.38 lei 6-12 zile |
| Hardback (1) | 609.48 lei 6-8 săpt. | |
| CRC Press – 10 apr 2023 | 609.48 lei 6-8 săpt. |
Preț: 308.75 lei
Preț vechi: 325.01 lei
-5% Nou
Puncte Express: 463
Preț estimativ în valută:
59.11€ • 61.44$ • 49.01£
59.11€ • 61.44$ • 49.01£
Carte disponibilă
Livrare economică 16-30 ianuarie 25
Livrare express 01-07 ianuarie 25 pentru 26.37 lei
Preluare comenzi: 021 569.72.76
Specificații
ISBN-13: 9780367489861
ISBN-10: 0367489864
Pagini: 170
Ilustrații: 42 Tables, black and white; 6 Line drawings, color; 10 Line drawings, black and white; 1 Halftones, color; 20 Halftones, black and white; 7 Illustrations, color; 30 Illustrations, black and white
Dimensiuni: 133 x 203 x 11 mm
Greutate: 0.31 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Pocket Guides to Biomedical Sciences
ISBN-10: 0367489864
Pagini: 170
Ilustrații: 42 Tables, black and white; 6 Line drawings, color; 10 Line drawings, black and white; 1 Halftones, color; 20 Halftones, black and white; 7 Illustrations, color; 30 Illustrations, black and white
Dimensiuni: 133 x 203 x 11 mm
Greutate: 0.31 kg
Ediția:1
Editura: CRC Press
Colecția CRC Press
Seria Pocket Guides to Biomedical Sciences
Public țintă
Adult education and PostgraduateCuprins
Chapter 1 - Vaccination of cattle
Chapter 2 - Guinea pig model to test the potency of IBR vaccines
Chapter 3 - Guinea pig model to test the potency of Rotavirus vaccines
Chapter 4 - Guinea pig model to test the potency of Bovine Parainfluenza Type 3 Virus vaccines
Chapter 5 - Guinea pig model to test the potency of BVDV vaccines
Chapter 6 - Guinea pig model application
References
Chapter 2 - Guinea pig model to test the potency of IBR vaccines
Chapter 3 - Guinea pig model to test the potency of Rotavirus vaccines
Chapter 4 - Guinea pig model to test the potency of Bovine Parainfluenza Type 3 Virus vaccines
Chapter 5 - Guinea pig model to test the potency of BVDV vaccines
Chapter 6 - Guinea pig model application
References
Notă biografică
Viviana Parreño, Biochemist (1995), Ph.D. in Veterinary Virology and Immunology (2002) and Master in Biometrics (2021), works since 1992 at The National Institute of Agricultural Technology, INTA, Argentina and is a member of CONICET scientific career since 2007. At the moment of writing the present book Dr Parreño is working as Visiting Research scientist at the Department of Biomedical Sciences and Pathobiology, Virginia-Maryland College of Veterinary Medicine, Virginia Polytechnic Institute and State University from July 2021-October 2022.
Dr Parreño was in charge of the VD-Lab (viral gastroenteritis lab) at the Virology Institute, INTA from 2004 to 2016. She has 30 years of research experience, including epidemiological studies of animal rotavirus, coronavirus and norovirus; development of vaccines and passive immune strategies to prevent calf and foal diarrhea; development of calf models of bovine rotavirus and coronavirus infection and disease; and development and characterization of llama derived-nanobodies; development and statistical validation of diagnosis kits including Rotadial, the first nanobody-based kit used in the hospitals of the acute diarrhea surveillance network of the Argentinean Ministry of health (INEI-ANLIS Malbran).
Dr. Parreño is co-founder and scientific coordinator of INCUINTA (2009 to present), the incubator of biotechnological platforms of INTA. She is one of the entrepreneurs who created of the public-private startup company BIOINNOVO (INTA-Vetanco S.A.) and participated actively in the development of three veterinary products in the market: Rotacoli Equina® Biochemic; BIOINNOVO IgY DNT® an IgY-based product to prevent calf diarrhea by RVA, Coronavirus, E coli and Salmonella and VEDEVAX®,a BVDV subunit targeted vaccine).
Starting from 2003 to present, Dr Parreno coordinated a large team of researchers and private partners to reach the development and statistical validation of the INTA guinea pig model for potency testing of bovine viral vaccines, the topic of this present book. The model was adopted as the official potency control test of vaccines administered to cattle in Argentina (SENASA- Animal Health Service Resol. 598.12), and it is expected to extend its use through CAMEVET and the World Organisation for Animal Health at a regional and worldwide level.
Dr Parreño was in charge of the VD-Lab (viral gastroenteritis lab) at the Virology Institute, INTA from 2004 to 2016. She has 30 years of research experience, including epidemiological studies of animal rotavirus, coronavirus and norovirus; development of vaccines and passive immune strategies to prevent calf and foal diarrhea; development of calf models of bovine rotavirus and coronavirus infection and disease; and development and characterization of llama derived-nanobodies; development and statistical validation of diagnosis kits including Rotadial, the first nanobody-based kit used in the hospitals of the acute diarrhea surveillance network of the Argentinean Ministry of health (INEI-ANLIS Malbran).
Dr. Parreño is co-founder and scientific coordinator of INCUINTA (2009 to present), the incubator of biotechnological platforms of INTA. She is one of the entrepreneurs who created of the public-private startup company BIOINNOVO (INTA-Vetanco S.A.) and participated actively in the development of three veterinary products in the market: Rotacoli Equina® Biochemic; BIOINNOVO IgY DNT® an IgY-based product to prevent calf diarrhea by RVA, Coronavirus, E coli and Salmonella and VEDEVAX®,a BVDV subunit targeted vaccine).
Starting from 2003 to present, Dr Parreno coordinated a large team of researchers and private partners to reach the development and statistical validation of the INTA guinea pig model for potency testing of bovine viral vaccines, the topic of this present book. The model was adopted as the official potency control test of vaccines administered to cattle in Argentina (SENASA- Animal Health Service Resol. 598.12), and it is expected to extend its use through CAMEVET and the World Organisation for Animal Health at a regional and worldwide level.
Descriere
This book summarizes the validation of a guinea pig model for potency testing combined vaccines applied in cattle to control the respiratory, reproductive, and neonatal calf diarrhea syndromes. The model allows, in one serum sample, to test the vaccine quality for all the viral antigens included in most formulations of bovine vaccines.